Xenetic Biosciences, Inc. (56)
Browse by Contract Category
Contracts
-
Statement of Work, dated June 30, 2022, between Xenetic Biosciences, Inc. and Catalent Pharma Solutions, LLC
(Filed With SEC on August 11, 2022)
-
Form of Subscription Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD
(Filed With SEC on August 11, 2022)
-
Exclusive License Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD
(Filed With SEC on August 11, 2022)
-
Second Work Order to Master Service Agreement, dated October 12, 2021, between the Company and PJSC Pharmsynthez
(Filed With SEC on March 22, 2022)
-
Exclusive Sublicense Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD
(Filed With SEC on August 11, 2022)
-
Amendment Number One to the Master Services Agreement, dated October 12, 2021, between the Company and PJSC Pharmsynthez
(Filed With SEC on March 22, 2022)
-
Exclusive License Agreement, dated December 20, 2021, between Lipoxen Technologies Limited and Public Joint-Stock Company Pharmsynthez
(Filed With SEC on March 22, 2022)
-
Novation of Agreement on Co-Development and the Terms of Exclusive License, dated December 17, 2021, between Xenetic Biosciences (UK) Limited (formerly Lipoxen plc), Lipoxen...
(Filed With SEC on March 22, 2022)
-
At The Market Offering Agreement by and between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated November 19, 2021
(Filed With SEC on November 19, 2021)
-
Form of Letter Agreement by and between Xenetic Biosciences, Inc. and the Holders, dated November 15, 2021
(Filed With SEC on November 16, 2021)
-
Form of Series B Warrant
(Filed With SEC on July 28, 2021)
-
Form of Series A Warrant
(Filed With SEC on July 28, 2021)
-
Form of Registration Rights Agreement, dated July 26, 2021, by and among the Company and the other parties thereto
(Filed With SEC on July 28, 2021)
-
Form of Securities Purchase Agreement, dated July 26, 2021, by and among the Company and the other parties thereto
(Filed With SEC on July 28, 2021)
-
Engagement Letter between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated as of July 25, 2021
(Filed With SEC on July 28, 2021)
-
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 16, 2021)
-
Engagement Letter between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated as of December 9, 2020
(Filed With SEC on December 14, 2020)
-
Form of Securities Purchase Agreement between Xenetic Biosciences, Inc. and the purchasers named therein, dated as of December 10, 2020
(Filed With SEC on December 14, 2020)
-
Work Order to Master Service Agreement, dated June 12, 2020, between the Company and PJSC Pharmsynthez
(Filed With SEC on August 12, 2020)
-
Master Service Agreement, dated June 12, 2020, between the Company and PJSC Pharmsynthez
(Filed With SEC on August 12, 2020)
-
Research Funding and Option Agreement, dated May 15, 2020, between the Company and the Scripps Research Institute
(Filed With SEC on August 12, 2020)
-
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 26, 2020)
-
Xenetic Biosciences, Inc. Stock Option Grant Notice, dated December 4, 2019, between Jeffrey Eisenberg and Xenetic Biosciences, Inc
(Filed With SEC on March 26, 2020)
-
Form of Xenetic Biosciences, Inc. Stock Option Grant Notice
(Filed With SEC on March 26, 2020)
-
Form of Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc
(Filed With SEC on March 26, 2020)
-
Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc. for Grigory G. Borisenko, effective as of September 26, 2019
(Filed With SEC on March 26, 2020)
-
Underwriting Agreement
(Filed With SEC on July 22, 2019)
-
Warrant Agency Agreement
(Filed With SEC on July 22, 2019)
-
Form of Purchase Warrant
(Filed With SEC on July 22, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on July 22, 2019)
-
Consent Agreement
(Filed With SEC on July 16, 2019)
-
Third Amendment to the OPKO Assignment Agreement
(Filed With SEC on July 16, 2019)
-
Third Amendment to the Share Purchase Agreement
(Filed With SEC on July 16, 2019)
-
Form of Purchase Warrant
(Filed With SEC on July 12, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on July 12, 2019)
-
Form of Purchase Warrant
(Filed With SEC on July 2, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on July 2, 2019)
-
Form of Warrant
(Filed With SEC on June 25, 2019)
-
CONSENT AGREEMENT
(Filed With SEC on June 25, 2019)
-
Second Amendment to the Share Purchase Agreement
(Filed With SEC on June 24, 2019)
-
Second Amendment to the OPKO Assignment Agreement
(Filed With SEC on June 24, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on June 24, 2019)
-
Form of Purchase Warrant
(Filed With SEC on June 24, 2019)
-
First Amendment to the OPKO Assignment Agreement
(Filed With SEC on June 13, 2019)
-
First Amendment to the Share Purchase Agreement
(Filed With SEC on June 13, 2019)
-
OPKO Assignment Agreement
(Filed With SEC on May 20, 2019)
-
Share Purchase Agreement
(Filed With SEC on May 13, 2019)
-
OPKO Assignment Agreement
(Filed With SEC on May 13, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on March 7, 2019)
-
Form of Purchase Warrant
(Filed With SEC on March 7, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on March 7, 2019)
-
Share Purchase Agreement
(Filed With SEC on March 4, 2019)
-
Voting Agreement Pharmsynthez
(Filed With SEC on March 4, 2019)
-
Voting Agreement Dr. Genkin
(Filed With SEC on March 4, 2019)
-
Voting Agreement OPKO
(Filed With SEC on March 4, 2019)
-
OPKO Assignment Agreement
(Filed With SEC on March 4, 2019)